🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 697947109 (prev. 720795103 )
- Market Cap
- Small Cap
- Previous Symbol
- PIRS (changed 12/16/2024)
- Previous Name
- Pieris Pharmaceuticals, Inc.
Business: Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.
Company Contact
- CEO
- Wes Kaupinen
- CFO
- Matthew E. Korenberg
- Headquarters
- 225 Franklin Street, 26th Floor, Boston, MA 02110
- Phone
- 857-246-8998
- Investor Relations
- Maria Kelman · 857-362-9635 · kelman@pieris.com